Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
RNA-based therapeutics face challenges in bioanalysis, with experts recommending strategies to improve LC–MS performance and standardize ADME and DMPK practices. GLP-1 therapies require careful ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback